Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Display:
?
Cancer Type/Condition:  Cancer- and cancer treatment-related conditions
Stage/Subtype:  nausea and vomiting
Country:  U.S.A.
Trial Type:  Supportive care
Results 1-11 of 11 for your search:
Start Over
Netupitant and Palonosetron Hydrochloride in Preventing Chronic Nausea and Vomiting in Patients with Cancer
Status: Active
Phase: Phase III, Phase II
Type: Supportive care
Age: 18 and over
Trial IDs: 2016-0843, NCI-2017-00599, NCT03040726
Ropivacaine Hydrochloride via Paravertebral Blocks before Surgery in Decreasing Pain in Patients with Breast Cancer
Status: Active
Phase: Phase III
Type: Supportive care
Age: 18 to 100
Trial IDs: J1284, NCI-2014-01365, 311945, NA_00075957, NCT02161705
Sugammadex or Neostigmine and Glycopyrrolate in Reducing Time to Muscle Strength Recovery after Surgery in Patients Undergoing Surgery
Status: Active
Phase: Phase III
Type: Supportive care, Treatment
Age: 18 and over
Trial IDs: 17-207, NCI-2017-00744, NCT03116997
Ondansetron with or without Aprepitant in Preventing Chemotherapy-Induced Nausea and Vomiting in Patients with Gliomas
Status: Active
Phase: Phase II
Type: Supportive care, Treatment
Age: 18 and over
Trial IDs: Pro00031206, NCI-2013-00520, NCT01450826
Fosaprepitant Dimeglumine, 5HT3 Receptor Antagonists, and Dexamethasone in Reducing Nausea and Vomiting in Patients with Germ Cell Tumors Undergoing Chemotherapy with Cisplatin
Status: Active
Phase: Phase II
Type: Supportive care
Age: 15 and over
Trial IDs: QL12-153, NCI-2013-00278, HOG QL12-153, 1211010041R001, 1211010041, NCT01736917
Rolapitant Hydrochloride in Preventing Nausea/Vomiting in Patients with Sarcoma Receiving Chemotherapy
Status: Active
Phase: Phase II
Type: Supportive care, Treatment
Age: 18 to 65
Trial IDs: 2015-0587, NCI-2016-00801, NCT02732015
Omalizumab in Reducing Refractory Type I Hypersensitivity Reactions in Patients with Cancer Receiving Chemotherapy
Status: Active
Phase: Phase I
Type: Supportive care
Age: 18 and over
Trial IDs: 13-485, NCI-2014-02030, NCT02118987
Fosaprepitant Dimeglumine and Granisetron Transdermal System in Preventing Nausea and Vomiting in Patients with Breast Cancer Undergoing Chemotherapy
Status: Active
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Supportive care
Age: 18 and over
Trial IDs: 1B-11-5, NCI-2012-01170, HS-11-00443, NCT01649258
Neuromuscular Electrical Stimulation of Acupoint P6 in Preventing Nausea and Vomiting after Surgery in Patients Undergoing Breast Surgery
Status: Active
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Supportive care
Age: 18 and over
Trial IDs: 2015-0170, NCI-2015-01519, NCT02473042
Electronic Patient Symptom Reporting in Reducing Symptom Burden during Hospitalization in Patients with Cancer Receiving Intensive Chemotherapy
Status: Active
Phase: No phase specified
Type: Supportive care
Age: 18 to 75
Trial IDs: LCCC 1404, NCI-2015-00404, 14-1043, NCT02574897
Alternative Approaches for Nausea Control
Status: Active
Phase: No phase specified
Type: Supportive care
Age: 18 and over
Trial IDs: UCCS1202, NCI-2017-00139, R01AT007474-01A1, NCT01695993
Start Over